CID 16130374

Rm-20 ologonucleotide-lipophilic group

Structural Information

Molecular Formula
C211H281N81O116P20
SMILES
CCCCCCCCCCCCCCCCCCNP(=O)(O)OCC1C(CC(O1)N2C=NC3=C2N=C(NC3=O)N)OP(=O)(O)OCC4C(CC(O4)N5C=CC(=NC5=O)N)OP(=O)(O)OCC6C(CC(O6)N7C=NC8=C(N=CN=C87)N)OP(=O)(O)OCC9C(CC(O9)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)O
InChI
InChI=1S/C211H281N81O116P20/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-27-253-409(310,311)350-58-117-106(50-158(380-117)288-89-248-169-186(288)261-198(225)266-193(169)296)399-419(330,331)355-63-122-102(41-149(375-122)278-33-25-141(217)259-208(278)306)395-415(322,323)361-68-127-107(45-153(381-127)283-84-243-164-175(220)231-78-237-181(164)283)400-423(338,339)360-67-126-105(44-152(379-126)281-56-95(3)192(295)272-211(281)309)398-418(328,329)354-62-121-101(40-148(374-121)277-32-24-140(216)258-207(277)305)394-414(320,321)362-69-128-108(46-154(382-128)284-85-244-165-176(221)232-79-238-182(165)284)401-424(340,341)365-72-131-111(49-157(385-131)287-88-247-168-179(224)235-82-241-185(168)287)404-427(346,347)367-74-133-113(52-160(387-133)290-91-250-171-188(290)263-200(227)268-195(171)298)407-422(336,337)358-65-124-103(42-150(377-124)279-34-26-142(218)260-209(279)307)396-416(324,325)364-71-130-109(47-155(384-130)285-86-245-166-177(222)233-80-239-183(166)285)402-425(342,343)366-73-132-112(51-159(386-132)289-90-249-170-187(289)262-199(226)267-194(170)297)406-421(334,335)357-64-123-99(38-146(376-123)275-30-22-138(214)256-205(275)303)392-412(316,317)359-66-125-104(43-151(378-125)280-55-94(2)191(294)271-210(280)308)397-417(326,327)353-61-120-98(37-145(373-120)274-29-21-137(213)255-204(274)302)391-411(314,315)352-60-119-100(39-147(372-119)276-31-23-139(215)257-206(276)304)393-413(318,319)363-70-129-110(48-156(383-129)286-87-246-167-178(223)234-81-240-184(167)286)403-426(344,345)368-75-134-115(54-162(388-134)292-93-252-173-190(292)265-202(229)270-197(173)300)408-428(348,349)369-76-135-114(53-161(389-135)291-92-251-172-189(291)264-201(228)269-196(172)299)405-420(332,333)356-59-118-97(36-144(371-118)273-28-20-136(212)254-203(273)301)390-410(312,313)351-57-116-96(293)35-143(370-116)282-83-242-163-174(219)230-77-236-180(163)282/h20-26,28-34,55-56,77-93,96-135,143-162,293H,4-19,27,35-54,57-76H2,1-3H3,(H,312,313)(H,314,315)(H,316,317)(H,318,319)(H,320,321)(H,322,323)(H,324,325)(H,326,327)(H,328,329)(H,330,331)(H,332,333)(H,334,335)(H,336,337)(H,338,339)(H,340,341)(H,342,343)(H,344,345)(H,346,347)(H,348,349)(H2,212,254,301)(H2,213,255,302)(H2,214,256,303)(H2,215,257,304)(H2,216,258,305)(H2,217,259,306)(H2,218,260,307)(H2,219,230,236)(H2,220,231,237)(H2,221,232,238)(H2,222,233,239)(H2,223,234,240)(H2,224,235,241)(H2,253,310,311)(H,271,294,308)(H,272,295,309)(H3,225,261,266,296)(H3,226,262,267,297)(H3,227,263,268,298)(H3,228,264,269,299)(H3,229,265,270,300)
InChIKey
WWJJOTPPYUFEOJ-UHFFFAOYSA-N
Compound name
[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(4-amino-2-oxopyrimidin-1-yl)-3-[[5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-N-octadecylphosphonamidic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

6424.333 Da
Monoisotopic Mass

-32.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 6425.3403 311.5
[M+Na]+ 6447.3222 311.5
[M-H]- 6423.3257 311.5
[M+NH4]+ 6442.3668 311.5
[M+K]+ 6463.2962 311.5
[M+H-H2O]+ 6407.3303 311.5
[M+HCOO]- 6469.3312 311.5
[M+CH3COO]- 6483.3469 311.5
[M+Na-2H]- 6445.3077 311.5
[M]+ 6424.3325 311.5
[M]- 6424.3335 311.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.